Orofacial findings of congenital generalized lipodystrophy: a systematic review
DOI:
https://doi.org/10.33448/rsd-v9i8.6659Keywords:
Congenital generalized lipodystrophy; Orofacial changes; Orofacial manifestations.Abstract
This study aims to verify the orofacial findings of congenital generalized lipodystrophy (LGC) in patients diagnosed with this condition. This is a systematic review of the literature, carried out in accordance with the PubMed, Web of Science and Scopus databases. 14 studies published in the last 15 years that addressed the orofacial clinical findings of LGC were included. LGC is a rare autosomal recessive condition, presenting a wide variety of manifestations that affect the oral and facial regions. The main orofacial findings identified were prognathism, absence of facial subcutaneous fat, prominent frontal and supraorbital protrusions, low frontal hairline, triangular face, facial hirsutism, macroglossia, labial hypertrophy, abnormal dental morphology, dental caries, tooth absences, diastemas and crowding dental. The results indicate that LGC can cause significant orofacial changes in individuals, and it is important that these patients are monitored by a multidisciplinary health team, and that these professionals have knowledge based on scientific evidence regarding these clinical findings, to offer a better prognosis for these patients.
References
Arif, A., Afzal, M. F., & Hamid, M. H. (2019). Berardinelli-Seip Syndrome: A Rare Autosomal Disorder. Annals of King Edward Medical University, 25(3), 1-3. Retrieved from https://annalskemu.org/journal/index.php/annals/article/view/3039
Bhujel, N., & Clark, H. (2016). Case report: Dental management of Berardinelli-Seip congenital lipodystrophy. European Archives of Paediatric Dentistry, 17(2), 137-140. doi: 10.1007 / s40368-015-0210-z
Chakraborty, P. P., Datta, S., Mukhopadhyay, S., & Chowdhury, S. (2016). Pseudoacromegaly in congenital generalised Lipodystrophy (Berardinelli-seip syndrome). BMJ Case Reports, 2016(1), 2–4. doi: 10.1136/bcr-2016-214493
Chen, X. X., & Yang T. (2015). Roles of leptin in bone metabolism and bone diseases. Journal of Bone and Mineral Metabolism, 33(1), 474-485. doi: 10.1007 / s00774-014-0569-7
Dal, A. I., & Patel, H. (2010). Berardinelli-Seip Syndrome. Online Journal of Health and Allied Sciences, 9(4), 28. Retrieved from http://cogprints.org/7275/1/2010-4-28.pdf
Durão, N., & Amarante, J. (2017). Osteossíntese no tratamento cirúrgico dos prognatismos: Estado da arte. Acta Médica Portuguesa, 30(3), 224-232. doi: 10.20344/amp.7788
Elefteriou, F., Takeda, S., Ebihara, K., Magre, J., Patano, N., Kim, C. (2004). Serum leptin level is a regulator of bone mass. Proceedings of the National Academy of Sciences of the United States of America, 101(9), 3258-3263. doi: 10.1073/pnas.0308744101
Eser, M., Ayaz, A., & Yeşil, G. (2017). A case with Rubinstein-Taybi syndrome: A novel frameshift mutation in the CREBBP gene. The Turkish Journal of Pediatrics, 59(5), 601-603. doi: 10.24953 / turkjped.2017.05.017
Friguls, B., Coroleu, W., Del-Alcazar, R., Hilbert, P, Van-Maldergem, L., & Pintos-Morell, G. (2009). Severe cardiac phenotype of Berardinelli-Seip congenital lipodystrophy in an infant with homozygous E189X BSCL2 mutation. European Journal of Medical Genetics, 52(1), 14-16. doi: 10.1016 / j.ejmg.2008.10.006
Hozhabri, H., Talebi, M., Mehrjardi, M. Y. V., Luca, A., & Dehghani, M. (2020). Martsolf syndrome with novel mutation in the TBC1D20 gene in a family from Iran. American Journal of Medical Genetics Part A, (5), 957-961. doi: 10.1002/ajmg.a.61543
Indumathi, C., Ayyar, V., & Lewin, S. (2011). Berardinelli Seip syndrome with insulin-resistant diabetes mellitus and stroke in an infant. Indian Journal of Endocrinology and Metabolism, 15(5), 62. doi: 10.4103 / 2230-8210.83054
Lima, D. L. F., Montenegro-Júnior, R. M., Fernandes, V. O., Barros, A. I. S., & Rêgo, D. M. (2007). Dental and periodontal alterations in Berardinelli-Seip syndrome. International Academy of Periodontology, 9(2), 63-67. Retrieved from https://europepmc.org/article/med/17506386
Lima, J. G., Nobrega, L. H. C., Lima, N. N., Santos, M. C. F., Baracho, M. F. P., & Bandeira, F. (2018). Bone Density in Patients With Berardinelli-Seip Congenital Lipodystrophy Is Higher in Trabecular Sites and in Type 2 Patients. Journal of Clinical Densitometry, 21(1), 61-67. doi: 10.1016 / j.jocd.2016.10.002
Medeiros, L. B. A., Dantas, V. K. C., Sarmento, A. S. C., Agnez-Lima, L. F., Meireles, A. L., & Nobre, T. T. X. (2017). High prevalence of Berardinelli-Seip Congenital Lipodystrophy in Rio Grande do Norte State, Northeast Brazil. Diabetology & Metabolic Syndrome, 9(1), 80. doi: 10.1186 / s13098-017-0280-7
Metwalley, K. A., & Farghaly, H. S. (2014). Berardinelli-Seip syndrome type 1 in an Egyptian child. Indian Journal of Human Genetics, 20(1), 75–78. doi: 10.4103/0971-6866.132762
Oswiecimska, J., Dawidziuk, M., Gambin, T., Ziora, K., Marek, M., & Rzonca, S. (2019). A Patient with Berardinelli-Seip Syndrome, Novel AGPAT2 Splicesite Mutation and Concomitant Development of Non-diabetic Polyneuropathy. Journal Of Clinical Research İn Pediatric Endocrinology, 11(3), 319-326. doi: 10.4274 / jcrpe.galenos.2018.2018.0227
Parenti, I., Teresa-Rodrigo, M. E., Pozojevic, J., Gil, S. R., & Bader, I., Braunholz, D.(2017). Mutations in chromatin regulators functionally link Cornelia de Lange syndrome and clinically overlapping phenotypes. Human Genetics, 136(3), 307-320. doi: 10.1007 / s00439-017-1758-y
Poovazhagi V., Shanthi S., Jahnavi S., Radha V., & Mohan, V. (2013). Berardinelli Seip congenital lipodystrophy presenting with neonatal diabetes mellitus due to a mutation in the AGPAT2 gene. International Journal of Diabetes in Developing, 33(1), 66-68. doi: 10.1007/s13410-013-0124-4
Purizaca-Rosillo, N., Mori, T., Benites-Cóndor, Y., Hisama, FM., & Martin, GM., Oshima, J. (2017). High incidence of BSCL2 intragenic recombinational mutation in Peruvian type 2 Berardinelli-Seip syndrome. American Journal of Medical Genetics,173(2). 471-478. doi: 10.1002 / ajmg.a.38053
Roth, T., Nair, S., & Kumar, A. (2010). Monogenic diabetes secondary to congenital lipodystrophy in a 14-year-old yemeni girl. Journal Of Clinical Research İn Pediatric Endocrinology, 2(4), 176-179. doi: 10.4274 / jcrpe.v2i4.176
Santos, I. C. C., Azevedo, M. F. C., & Batista, V. L. C. (2020). Síndrome de Berardinelli – Um Relato de Caso em Manaus, Amazonas. European Academic Research, 8(1), 155-163. Retrieved from www.euacademic.com
Serino, D., Davico, C., Specchio, N., Marras, C. E., & Fioretto, F. (2019). Berardinelli-Seip syndrome and progressive myoclonus epilepsy. Epileptic Disorders, 21(1), 117-121. doi: 10.1684 / epd.2019.1038
Shahbaz, A., Aziz, K., Umair, M., Malik, Z. R., Awan, S. I., & Sachmechi, I. (2018). Amyloidosis Presenting with Macroglossia. The Cureus Journal of Medical Science,10(8), e3185. doi: 10.7759 / cureus.3185
Shawky, R. M., Gamal, R., & Seifeldin, N. S. (2015). Berardinelli–Seip syndrome type 2 – An Egyptian child. Egyptian Journal of Medical Human Genetics, 16(2), 189-193. doi: 10.1016/j.ejmhg.2014.08.004
Shetty, S., Chapla A., Kapoor, N., Thomas, N., & Vizhalil-Paul, T. (2016). A Novel Variant of the Agpat2 Mutation in Generalized Congenital Lipodystrophy. Australasian Medical Journal, 9(6), 164-168. doi: 10.21767 / AMJ.2016.2640
Solanki, M., Patil, S. S., Baweja, D K., Noorani, H., & P. K. S. (2008). Talon cusps, macrodontia, and aberrant tooth morphology in Berardinelli-Seip syndrome. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology, 105(1), 41-47. doi: 10.1016/j.tripleo.2007.07.022
Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., & Parker, KL. (2002). Leptin regulates bone formation via the sympathetic nervous system. Cell, 111(3), 305-317. doi: 10.1016/S0092-8674(02)01049-8
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Juliana Campos Pinheiro, Lucas Cavalcante de Sousa, Amanda de Medeiros Amancio, Érika Giovana Carvalho da Silva, Francisca Jennifer Duarte de Oliveira, Gabriel Coutinho Gonçalves, Dennys Ramon de Melo Fernandes Almeida, Gabriel Gomes da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.